@jimcramer 👋😎Checkout $CLRB #stocks 

Cellectar Granted EU Patent 

FDA Grants Fast Track Designation.
FDA supports regulatory approval pathway for WM/LPL.
Insiders, CEO &amp; team purchasing large amounts of shares recently. First PT $3+. Then $6-10+ 

CATALYST -&gt; EST COMP. DATE July 2020